It was reported to boston scientific corporation on (b)(6) 2015 that a partially covered wallflex¿ esophageal stent was implanted in the mid-esophagus during an esophageal stent placement procedure performed on (b)(6) 2015.There were no complications during the procedure and the patient was released from the hospital on (b)(6) 2015.Reportedly, the patient was diagnosed with cancer in 2007 and was treated with cytostatic and chemotherapy and was stable for many years.The patient had undergone cancer treatments (chemotherapy and radiotherapy) multiple times over the past ten years.In the beginning of (b)(6) 2015 the patient experienced symptoms of dysphagia and had trouble eating and drinking.Therefore, the surgeon decided to place a partially covered wallflex¿ esophageal stent to open up the lumen.On (b)(6)2015, the patient went to the emergency room with a feeling of sickness, fever, and dysphagia.The physician noted that the patient experienced heavy bleeding from the mouth/stomach and believes that the stent may have perforated the aorta.The patient expired on (b)(6) 2015 as a result of this event.According to the physician, the patients cancer may have involved the mediastinum and the lungs.In the physician's assessment, the cause of death may have been due to a perforation of the aorta.
|
The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.It was reported the device was not used past its expiry date.The complainant indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|